Skip to content
Search

Latest Stories

EU set to cut costs from duplication of medical tests, wider use of interoperable electronic health data

The European Commission wants to make health data easier to access for patients, medics, regulators and researchers in a bid to improve diagnoses, cut unnecessary costs from duplication of medical tests and boost medicine research, an EU document says.

The document which is being published today outlines the EU executive's plans for a European health data space which Brussels estimates would lead to large savings and economic gains of more than 10 billion euros in 10 years.


EU patients spend 1.4 billion euros every year on unnecessary medical images alone, the document said, estimating that one in 10 X-rays or ultrasound tests are not needed because they are usually duplications of existing valid images.

Electronic prescriptions

Wider use of easily accessible electronic prescriptions is also estimated to lead to large savings by reducing errors in dispensing medicines. Many states still use paper prescriptions.

The proliferation of unneeded tests and prescribed drugs is caused mostly by problems in accessing health data, because often health information is not accessible to patients themselves and hospitals only partly share data with each other.

"People cannot always easily access their health data electronically, and if they want to consult doctors in more than one hospital or medical centre, they often cannot share the data with other health professionals," the document said.

Interoperable health data

The EU commission believes it could address the problem by making data more accessible to patients through the creation of databases which are freely accessible online.

EU health commissioner Stella Kyriakides has said easier access to health data would also greatly help patients with serious conditions, such as cancer, by improving diagnoses.

Under the plan, healthcare providers would be required to produce electronic health data that are interoperable.

Data generated from patients' health records and wellness apps would be pooled in compatible formats and made accessible to patients, regulators and researchers under strict rules to protect privacy, the document says. Stronger cybersecurity is also planned.

The Commission estimates that easier access to anonymised health records for analysts and data professionals could lead to 5.4 billion euros in economic gains in a decade thanks to more effective research and cheaper drugs.

Another 5.5 billion euros in gains would come from savings for patients and healthcare providers, and from "faster growth of the digital health and wellness applications markets".

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less